BlackRock Health Sciences Term Trust to Issue Monthly Dividend of $0.09 (NYSE:BMEZ)

BlackRock Health Sciences Term Trust (NYSE:BMEZGet Free Report) announced a monthly dividend on Thursday, February 1st, Zacks reports. Shareholders of record on Thursday, February 15th will be given a dividend of 0.09 per share on Thursday, February 29th. This represents a $1.08 annualized dividend and a yield of 6.76%. The ex-dividend date is Wednesday, February 14th.

BlackRock Health Sciences Term Trust has raised its dividend payment by an average of 16.5% per year over the last three years.

BlackRock Health Sciences Term Trust Stock Performance

BMEZ stock opened at 15.98 on Monday. The firm’s 50-day moving average price is 14.92 and its two-hundred day moving average price is 14.68. BlackRock Health Sciences Term Trust has a 12-month low of 12.93 and a 12-month high of 16.95.

Insider Buying and Selling at BlackRock Health Sciences Term Trust

In other news, major shareholder Saba Capital Management, L.P. acquired 95,390 shares of the firm’s stock in a transaction on Friday, November 17th. The shares were purchased at an average price of 13.59 per share, for a total transaction of 1,296,350.10. Following the completion of the transaction, the insider now owns 13,322,293 shares of the company’s stock, valued at 181,049,961.87. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Over the last quarter, insiders have bought 3,536,825 shares of company stock worth $51,450,341.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

Several hedge funds and other institutional investors have recently modified their holdings of BMEZ. Sunbelt Securities Inc. purchased a new position in shares of BlackRock Health Sciences Term Trust during the first quarter valued at about $28,000. MUFG Americas Holdings Corp purchased a new position in shares of BlackRock Health Sciences Term Trust during the third quarter valued at about $30,000. Tower Research Capital LLC TRC increased its position in shares of BlackRock Health Sciences Term Trust by 9,113.3% during the third quarter. Tower Research Capital LLC TRC now owns 2,764 shares of the company’s stock valued at $40,000 after buying an additional 2,734 shares during the period. Harbour Investments Inc. purchased a new stake in BlackRock Health Sciences Term Trust in the fourth quarter worth about $89,000. Finally, CI Private Wealth LLC purchased a new stake in BlackRock Health Sciences Term Trust in the fourth quarter worth about $172,000.

About BlackRock Health Sciences Term Trust

(Get Free Report)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

Featured Articles

Dividend History for BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.